In the first half of 2020, the revolutionary global clinical trial for brain cancer patients, GBM AGILE, continues to make impressive progress and achieve milestones. AFCR supported its conception in 2013 to expeditiously develop new effective treatments for GBM brain cancer patients…
A global clinical trial to allow more patients to quickly share benefits of more effective treatments
Speech by AFCR Founder and CEO Dr. Ba Sujuan at the Beijing GBM AGILE Press Conference
(21 January, 2016) Brain cancer patients are remarkably courageous. So are their caregivers, families and friends. The financial and emotional burden to GBM patients and indeed all…
What is Glioblastoma (GBM)?
Glioblastoma, referred to simply as GBM, is the deadliest type of brain cancer. GBM is widely regarded as incurable and universally fatal, killing 95% of patients within five years of diagnosis. GBM survival rates have not improved in…
Global Collaborative Platforms
HomeGlobal Collaborative Platforms
Women Venture Competition
July 29, 2024 Global Collaborative Platforms…
Innovative Therapies and Treatments
HomeInnovative Therapies and Treatments
Building Safer, More Effective CAR-T Cell Therapies…
About the BRACE Award
HomeAbout the BRACE Award
Program Overview The Asian Fund for Cancer Research (AFCR) is proud to present the Bridging Research from Academia to Cancer Entrepreneurship (BRACE) Award Venture Competition. The BRACE Award aims to provide vital support to early-stage biotechs,…
Research Program
HomeResearch Program
Funded Cancer Research
Breakthroughs in cancer research require connections, collaboration and dedicated efforts from scientists and clinicians. AFCR is dedicated to sponsoring and supporting innovative research projects that unlock new information about how cancer forms and spreads, and, most…
Standing Together for a Greater Cause
In a remarkable display of unity, Dr. Sujuan B., CEO of the Asian Fund for Cancer Research (AFCR), and Dr. Kwok Leung, CFO, proudly stood shoulder to shoulder with the Global Coalition for Adaptive…
I am writing today to ask for your 2022 Annual Fund renewal gift to the Asian Fund for Cancer Research, and your decision is absolutely crucial! Currently, talented scientists are waiting for funding to pursue potentially life-saving research projects . Generous friends…